DIFFICULT-TO-TREAT ASTHMA IN CHILDREN

Download full text PDF
Issue: 
2
Year: 
2017

S. Dyakova, Candidate of Medical Sciences; N. Lev, Candidate of Medical Sciences; M. Kostyuchenko, Candidate of Medical Sciences; Professor Yu. Mizernitsky, MD; Professor N. Rozinova, MD Acad. Yu.E. Veltishchev Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research Medical University, Moscow

A clinical example is used to discuss criteria for distinguishing difficult-to-treat asthma from severe asthma in children, to demonstrate different ways of complex monitoring of asthmatic children for the assessment of control over disease course: dynamic assessment of asthma control test values, spirometric data, and nitric oxide and carbon monoxide levels in exhaled air; regular audit of compliance with elimination measures, basic therapy, and inhalation techniques; smoking cessation; and consideration of comorbidities.
Keywords: 
pulmonology
asthma
children
compliance
control
monitoring
nitric oxide
carbon monoxide

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. GINA Report, Global Strategy for Asthma Management and Prevention. PublishedNovember 2016. http://www.ginasthma.org
  2. Bronhial'naja astma u detej: strategija lechenija i profilaktika. – Natsional'naja programma (5-e izd.) / M., 2017; 132 s.
  3. Belevskij A.S. Pravil'naja otsenka kontrolja zabolevanija – objazatel'noe uslovie adekvatnoj terapii bronhial'noj astmy // Atmosfera. Pul'monol. i allergol. – 2007; 1: 25–9.
  4. Demko I.V., Sobko E.A., Kraposhina A.Ju. i dr. Uroven' kontrolja u bol'nyh bronhial'noj astmoj v klinicheskoj praktike // Pul'monologija. – 2011; 4: 76–9.
  5. Chernjak B.A., Vorzheva I.I. Kontroliruemoe techenie bronhial'noj astmy kak osnovnaja tsel' terapii v povsednevnoj klinicheskoj praktike // Atmosfera. Pul'monol. i allergol. – 2008; 2: 34–8.
  6. Voorend van Bergen S., Vaessen-Verberne A., Brackel H. et al. Monitoring strategies in children with asthma: a randomized controlled trial // Thorax. – 2015; 70: 543–50.
  7. Ahverdieva M.K., Katel'nitskaja L.I., Kolmakova T.S. i dr. Puti optimizatsii antismokingovoj politiki v molodezhnoj srede. V kn.: Materialy Vserossijskoj nauchnoj konferentsii «Aktual'nye problemy profilaktiki neinfektsionnyh zabolevanij» / M., 1999; 2: 4.
  8. Tsyplenkova S.E., Mizernitskij Ju.L. Klinicheskoe znachenie opredelenija oksida azota v vydyhaemom vozduhe pri zabolevanijah legkih u detej // Ros. vestn. perinatol. i pediat. – 2005; 6 (50): 16–21.
  9. Tsyplenkova S.E., Mizernitskij Ju.L. Oksid azota v vydyhaemom vozduhe: kliniko-funktsional'nye paralleli pri bronhial'noj astme u detej // Allergologija. – 2006; 2: 48–53.
  10. Majid H., Kao C. Utility of exhaled nitric oxide in the diagnosis and management of asthma // Curr. Opin. Pulm. Med. – 2010; 16 (1): 42–7.
  11. Van Veen I., Ten Brinke A., Sterk P. et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma // Eur. Respir. J. – 2008; 32: 344–9.
  12. Tsyplenkova S.E., Mizernitskij Ju.L., Sokolova L.V. i dr. Omalizumab: innovatsionnyj podhod k terapii nekontroliruemoj tjazheloj bronhial'noj astmy i komorbidnyh zabolevanij u detej // Ros. allergol. zhurn. – 2014; 5: 57–60.
  13. Tsyplenkova S.E., Mizernitskij Ju.L., Sokolova L.V. i dr. Novye vozmozhnosti kontrolja effektivnosti anti-IgE-terapii pri tjazheloj bronhial'noj astme u detej // Ros. vestn. perinatol. i pediat. – 2013; 3 (58): 47–54.